
IMARA IMRA
Quarterly report 2025-Q3
added 11-12-2025
IMARA P/E Ratio 2011-2025 | IMRA
Annual P/E Ratio IMARA
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.14 | -0.434 | -0.641 | -5.41 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.434 | -5.41 | -2.41 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-6.11 | $ 4.93 | 4.78 % | $ 818 M | ||
|
Aclaris Therapeutics
ACRS
|
-1.15 | $ 3.2 | -1.69 % | $ 247 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
-0.0368 | $ 1.07 | -5.75 % | $ 295 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 213.33 | -3.22 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.13 | -4.96 % | $ 7.53 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
BioVie
BIVI
|
-0.139 | $ 1.42 | -1.85 % | $ 2.1 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-18 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 93.93 | -0.93 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
8.2 | $ 26.45 | 4.67 % | $ 1.28 B | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
-4.51 | $ 9.6 | 0.37 % | $ 141 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 0.26 | -6.98 % | $ 566 M | ||
|
Catalyst Biosciences
CBIO
|
-0.393 | $ 12.98 | -7.91 % | $ 854 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.16 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-4.62 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
106 | $ 548.58 | -2.78 % | $ 41.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.37 | 2.83 % | $ 14.9 M | ||
|
AstraZeneca PLC
AZN
|
706 | $ 91.59 | 1.95 % | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
-0.00833 | $ 27.09 | -1.53 % | $ 1.74 M | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
-2 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
12.2 | $ 8.97 | -0.44 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.2 | $ 11.33 | -1.78 % | $ 733 M | ||
|
Biogen
BIIB
|
11.9 | $ 175.2 | 0.63 % | $ 25.5 B | ||
|
Abeona Therapeutics
ABEO
|
-2.76 | $ 5.07 | -5.5 % | $ 108 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
46.4 | $ 87.67 | -0.36 % | $ 9.05 B | ||
|
ADiTx Therapeutics
ADTX
|
-0.00147 | $ 1.43 | -36.18 % | $ 18.8 K | ||
|
Cellectar Biosciences
CLRB
|
-1.04 | $ 3.28 | -9.39 % | $ 40.1 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.333 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-1.19 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
14.9 | $ 24.29 | 2.84 % | $ 2.88 B |